The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis.
Mucosal Immunol
2017
10
2
421-433
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
2018
390
10114
2790-2802
Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation.
Oncology Research and Treatment
2017
40
11
691-696
Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma.
Leukemia
2017
31
8
1816-1819
Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.
Leukemia
2017
31
6
1463-1466
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM).
Leukemia
2017
31
6
1363-1367
[Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.
Theranostics
2017
7
9
2350-2362
Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes.
Oncotarget
2017
8
70
115002-115017